MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-07-0008898
Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals Private Limited - chemicals in Cuttack, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.2 Lakh
▼ 8% YoY
Net profit · FY 2025
₹14,120
Net margin 1.3%
EBITDA · FY 2025
₹17,041
EBITDA margin 1.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹12 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Fronde Pharmaceuticals Private Limited
Data last updated:
Fronde Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 20 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2012PTC015264. Its GSTIN is 21AACCF0363N1ZU (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors including Sagar Kumar Nayak (Managing Director) and Mansi Mohapatra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – B.L.Nayak At/Po – Arunoday Nagar Opposite High Court Colony, Cuttack, Odisha, India – 753012.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.2 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹14,120 (net margin 1.3%) and EBITDA of ₹17,041 (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 3% over five years.
Fronde Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-07-0008898). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Fronde Pharmaceuticals Private Limited
CIN U24230OR2012PTC015264
Registration Number 015264
Incorporation Date 20 April 2012
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-07-0008898
Recognitions & Rankings of Fronde Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – B.L.Nayak At/Po – Arunoday Nagar Opposite High Court Colony, Cuttack, Odisha, India – 753012
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Fronde Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Fronde Pharmaceuticals Private Limited
The main business activity of Fronde Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fronde Pharmaceuticals Private Limited FY 2025 filings available
Fronde Pharmaceuticals Private Limited reported revenue of ₹11.2 Lakh (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹11.2 Lakh ▼ 8%
Net profit · FY 2025
₹14,120 margin 1.3%
EBITDA · FY 2025
₹17,041 margin 1.5%
Compounded Annual Growth Rate (CAGR) of Fronde Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 9%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 47%
3 years · compounded
▲ 32%
5 years · compounded
▲ 17%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 8% fall in the latest year. EBITDA fell 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Fronde Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17,041 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14,120 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Fronde Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fronde Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mansi Mohapatra Also directs: BRCM Enterprises Private Limited | Director | 29 Jan 2024 | 2 Years 8 Months | Current |
| Sagar Kumar Nayak | Managing Director | 20 Apr 2012 | 14 Years 6 Months | Current |
| Anjan Kumar Behera | Director | 20 Apr 2012 | 14 Years 6 Months | Current |
Peer Comparison of Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Life Edge Pharmaceuticals Private Limited | ₹11.25 Lakh (FY 2025) | •••• | •••• | 170.0% | •••• | Pune, Maharashtra, India |
| Delbert Pharmaceuticals Private Limited | ₹11.25 Lakh (FY 2020) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Brugen Pharmaceuticals Private Limited | ₹11.23 Lakh (FY 2025) | •••• | •••• | 88.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Panmed Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2017) | •••• | •••• | -49.0% | •••• | Chennai, Tamil Nadu, India |
| Rynn Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2024) | •••• | •••• | -39.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Fronde Pharmaceuticals Private Limited this company | ₹11.2 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Cuttack, Odisha, India |
| Altmann Pharmaceuticals Private Limited | ₹11.17 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | Karnal, Haryana, India |
| Specura Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Pune, Maharashtra, India |
| Lifecord Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2019) | •••• | •••• | 132.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Lion in Pharmaceuticals India Private Limited | ₹11.13 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Yelahanka, Karnataka, India |
| HCLK Pharmaceuticals Private Limited | ₹11.11 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Fronde Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Fronde Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Fronde Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Fronde Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Mansi Mohapatra was appointed as Director on 29 Jan 2024.
AGM
Fronde Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fronde Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Appointed
Mansi Mohapatra was appointed as Director.
Ceased
Bibhuti Bhusan Das ceased to be Director.
Ceased
Arunav Nayak ceased to be Director.
Appointed
Anjan Kumar Behera was appointed as Director.
Appointed
Sagar Kumar Nayak was appointed as Managing Director.
Incorporation
20 Apr 2012
Fronde Pharmaceuticals Private Limited was registered on 20 Apr 2012 with Roc Cuttack & aged 14 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Fronde Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fronde Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fronde Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AACCF0363N1ZU | Odisha | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fronde Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fronde Pharmaceuticals Private Limited
Fronde Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in chemical products, within the chemicals industry. It was incorporated on 20 April 2012 (14+ years old) and is registered under CIN U24230OR2012PTC015264.
Fronde Pharmaceuticals reported revenue of ₹11.2 Lakh for FY 2025 (down 8% YoY).
Fronde Pharmaceuticals has 3 current directors:
- Sagar Kumar Nayak - Managing Director
- Mansi Mohapatra - Director
- Anjan Kumar Behera - Director
Fronde Pharmaceuticals reported a net profit of ₹14,120 (net margin 1.3%) and EBITDA of ₹17,041 (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Fronde Pharmaceuticals is 9% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Fronde Pharmaceuticals is 21AACCF0363N1ZU, registered in Odisha.
The CIN (Corporate Identification Number) of Fronde Pharmaceuticals is U24230OR2012PTC015264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fronde Pharmaceuticals was incorporated on 20 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Fronde Pharmaceuticals by revenue are Life Edge Pharmaceuticals Private Limited, Delbert Pharmaceuticals Private Limited, Brugen Pharmaceuticals Private Limited, Panmed Pharmaceuticals Private Limited, Rynn Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mansi Mohapatra was appointed as Director on 29 Jan 2024. Bibhuti Bhusan Das ceased to be Director on 24 Apr 2019. Arunav Nayak ceased to be Director on 02 Nov 2015. Fronde Pharmaceuticals has 5 board changes on record in total.
Yes, Fronde Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-07-0008898).